A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer.
Ipsen’s Iqirvo wins European approval for primary biliary cholangitis – Pharmaceutical Technology
The decision in Europe follows an accelerated approval by the FDA earlier this year. Image credit: Shutterstock / Ekaterina Markelova. The European Commission (EC) has
September 23, 2024